Clinical Trial Update: Clinical Study of SN301A Injection in the Treatment of Hepatocellular Carcinoma [EARLY_Phase 1]

View source ↗

Summary

This document reports an ongoing EARLY Phase 1 clinical trial evaluating SN301A Injection for hepatocellular carcinoma, sponsored by Shanghai General Hospital a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• SN301A Injection

Snippet

Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | Conditions: Hepatocellular Carcinoma (HCC) | EARLY_Phase 1 | Status: RECRUITING